Pfizer starts mid-stage trial for vaccine against Omicron subvariantAn illustration, created at the Centers for Disease Control and Prevention (CDC), depicts the 2019 Novel Coronavirus(photo credit: MAM/CDC/HANDOUT VIA REUTERS)
